跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
公共衛生學系
臺北醫學大學
公共衛生學院
電話
+886-2-27361661#6509
電子郵件
[email protected]
網站
http://ph.tmu.edu.tw
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(24)
專案
(354)
研究成果
(1833)
資料集
(59)
活動
(1)
指紋
查看啟用 公共衛生學系 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
81%
Apoplexy
69%
Odds Ratio
67%
Cohort Analysis
61%
Randomized Controlled Trial
59%
Urinary System
44%
Brain Ischemia
42%
Chronic Kidney Disease
33%
Malignant Neoplasm
31%
Particular Matter 2.5
29%
Prevalence
29%
Methylation
29%
Hazard Ratio
29%
Disease
27%
Logistic Regression Analysis
27%
Diabetes
24%
Infection
22%
Atmospheric Aerosol
22%
Diabetes Mellitus
22%
Network Meta-Analysis
21%
Cross Sectional Study
21%
COVID-19
20%
Transitional Cell Carcinoma
19%
Biological Marker
19%
Case-Control Study
18%
Chronic Obstructive Pulmonary Disease
18%
Cigarette Smoking
17%
Body Mass Index
16%
Proportional Hazards Model
16%
Health Survey
16%
Low Birth Weight
16%
Breast Cancer
15%
Long-Term Care
15%
Cancer Risk
14%
Childbirth
14%
Symptom
14%
Quality of Life
14%
Public Health
13%
Premature Labor
13%
Adolescent
13%
Hepatocellular Carcinoma
13%
Obstructive Sleep Apnea
13%
Retrospective Cohort Study
13%
Injury
13%
Prospective Cohort Study
12%
Blood Pressure
12%
Human Immunodeficiency Virus
12%
Cesarean Section
12%
Diagnosis
12%
Maturity Onset Diabetes of the Young
12%
Dose Response
12%
Small for Gestational Age
12%
Medicine
12%
Lung Cancer
11%
Health Care
11%
Diagnostic Accuracy
11%
Adverse Event
10%
Metabolic Syndrome
10%
Postoperative Pain
10%
Cardiovascular Disease
10%
Birth Outcomes
10%
Smoking
10%
Computer Assisted Tomography
10%
Household
10%
Ischemic Heart Disease
10%
Multilevel Analysis
10%
Carotid Atherosclerosis
10%
Cerebral Hemorrhage
10%
Medical Care
9%
Drug Therapy
9%
Fine Particulate Matter
9%
Survival Rate
9%
Hemoglobin A1c
9%
Evidence-Based Medicine
9%
Bladder Cancer
9%
Population
9%
Prenatal Care
8%
Intima-Media Thickness
8%
Atherosclerosis
8%
Emergency Department
8%
Polycyclic Aromatic Hydrocarbon
8%
Mortality Rate
8%
Health Care Cost
8%
Blackfoot Disease
8%
Retrospective Study
8%
Well Water
8%
Monocyte
8%
Cardiovascular System
8%
Disseminated Herpes Zoster
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Lymphocyte
8%
Proton-Pump Inhibitor
8%
Hemodialysis
7%
Emphysema
7%
Physical Activity
7%
Cytotoxicity
7%
Alcohol Consumption
7%
Diagnostic Performance
7%
Neutrophil
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
95%
Disease
54%
Malignant Neoplasm
46%
Transitional Cell Carcinoma
44%
Inflammation
44%
Prevalence
39%
Chronic Kidney Failure
38%
Brain Ischemia
36%
Randomized Controlled Trial
35%
Biological Marker
31%
Cardiovascular Disease
31%
Chronic Obstructive Lung Disease
30%
Cigarette Smoking
28%
Well Water
27%
Mouse
24%
Diabetes Mellitus
24%
Case-Control Study
23%
Infection
22%
Polycyclic Aromatic Hydrocarbon
21%
Long Term Exposure
20%
Comorbidity
19%
Dose-Response Relationship
19%
Low Birth Weight
19%
Bladder Cancer
18%
Carotid Atherosclerosis
17%
Sleep Disordered Breathing
17%
Interleukin 6
16%
Adverse Event
16%
Hemodialysis
16%
Glutathione
15%
Methanearsonic Acid
15%
Emphysema
15%
C Reactive Protein
15%
Ischemic Heart Disease
14%
Developmental Delay
14%
Lung Cancer
14%
Cacodylic Acid
14%
Tumor Necrosis Factor
13%
Tigecycline
13%
Transferase
13%
Cytotoxicity
13%
High Performance Liquid Chromatography
12%
Non Insulin Dependent Diabetes Mellitus
12%
Health Hazard
12%
Reactive Oxygen Metabolite
12%
Injury
12%
Overall Survival
12%
Cross-Sectional Study
11%
Zinc Oxide Nanoparticle
11%
Oyster
11%
Carbon Black
11%
Organic Carbon
11%
Premature Labor
11%
Small for Date Infant
11%
Epidermal Growth Factor Receptor
11%
Antiinfective Agent
11%
Blackfoot Disease
11%
Prospective Cohort Study
11%
Metabolic Syndrome X
11%
Symptom
10%
8 Hydroxydeoxyguanosine
10%
Chemotherapy
10%
Cigarette Smoke
10%
Proton Pump Inhibitor
9%
Normal Human
9%
Renal Cell Carcinoma
9%
End Stage Renal Disease
9%
Atherosclerosis
9%
Ethanol
9%
Recurrent Disease
9%
Cerebrovascular Disease
9%
Vaccination Policy
9%
Breast Cancer
9%
Hepatitis B Virus
9%
Cardiovascular Risk
9%
Colorectal Cancer
9%
Mortality Rate
8%
Nitric Oxide
8%
Heme Oxygenase 1
8%
Hepatitis B
8%
Placebo
8%
Volatile Organic Compound
8%
Brain Hemorrhage
8%
Attention Deficit Disorder
8%
Liver Cell Carcinoma
8%
Survival Rate
8%
Hyperlipidemia
7%
Respiratory Tract Disease
7%
Protein P53
7%
Asthma
7%
Nitrogen Dioxide
7%
Chronic Hepatitis B
7%
Bioaerosol
7%
Virus Hepatitis
7%
Antioxidant
7%
Cell Viability
7%
Lactate Dehydrogenase
7%
Neoplasm
7%
Heavy Metal
6%
Acetylsalicylic Acid
6%
Nursing and Health Professions
Confidence Interval
85%
Odds Ratio
60%
Meta Analysis
60%
Cohort Analysis
45%
Systematic Review
39%
Prevalence
34%
Logistic Regression Analysis
31%
Disease
29%
Cross-Sectional Study
28%
Adolescent
22%
Cigarette Filter
20%
Symptom
20%
Quality of Life
20%
National Health Insurance
19%
Practice Guideline
18%
Long Term Care
18%
Health Care Personnel
17%
Human Immunodeficiency Virus
16%
Health Survey
16%
Health Service
15%
Bibliometrics
15%
Hazard Ratio
14%
Pregnancy Outcome
14%
Diabetes Mellitus
14%
Case-Control Study
14%
Cardiovascular Disease
14%
Health Literacy
13%
Hospital
13%
Blood Pressure
13%
Injury
12%
Brain Ischemia
12%
Metabolic Syndrome X
12%
Chronic Kidney Failure
12%
Severe Acute Respiratory Syndrome
12%
Breast Cancer
11%
Mental Health
11%
Depression
11%
Low Birth Weight
11%
Infection
11%
Drug Therapy
11%
Traumatic Brain Injury
11%
Hemodialysis
10%
Gender Difference
10%
Mortality Rate
10%
Comorbidity
10%
Multilevel Analysis
9%
Independent Practice Association
9%
Malignant Neoplasm
9%
Health Status
9%
Hyperlipidemia
9%
Hepatitis B
8%
Outpatient
8%
Asthma
8%
Multivariate Logistic Regression Analysis
8%
Loneliness
8%
Transitional Cell Carcinoma
8%
Network Meta-Analysis
8%
Chronic Disease
8%
Head Injury
8%
Body Mass
7%
Socioeconomic Status
7%
Reimbursement
7%
Home Care
7%
Postoperative Pain
7%
Self Care
7%
World Health Organization
7%
Live Birth
6%
Panic
6%
Linear Regression Analysis
6%
Virus Hepatitis
6%
Medline
6%
Survival Rate
6%
Hepatitis C
6%
Vaccination Policy
6%
Cochrane Library
6%
Prenatal Care
5%
Intensive Care Unit
5%
Health Care Utilization
5%
Physician
5%
Diagnosis
5%
Chronic Hepatitis
5%
Insulin Resistance
5%
University Hospital
5%
Receiver Operating Characteristic
5%
Patient with Type 2 Diabetes
5%
Hemoglobin A1c
5%
Vaccine Efficacy
5%
Analysis of Variance
5%
Psychiatrist
5%
Tobacco Control
5%
Virus Infection
5%
Infant Mortality
5%
Acute Heart Infarction
5%
Clinical Outcome
5%
Lung Cancer
5%
Diagnostic Accuracy
5%
Prophylaxis
5%
Methylation
5%
Sleep Disordered Breathing
5%
Tobacco Smoke
5%